Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders (NCT04739423) | CuraSen Therapeutics, Inc. | 2021-06-28 |
Track Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia automatically
Every clearance here is in the API, with alerts when new ones post.